These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 36429083)

  • 1. Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas.
    Tang X; Guo D; Yang X; Chen R; Jiang Q; Zeng Z; Li Y; Li Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429083
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
    Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
    Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
    Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
    Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer.
    Dong B; Wu Y; Zhang J; Gu Y; Xie R; He X; Pang X; Wang X; Cui Y
    Front Immunol; 2023; 14():1162876. PubMed ID: 37215130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma.
    Hu Y; Cai J; Ye M; Mou Q; Zhao B; Sun Q; Lou X; Zhang H; Zhao Y
    Front Immunol; 2022; 13():1037128. PubMed ID: 36466923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of redox-related genes on tumor microenvironment immune characteristics and prognosis of high-grade gliomas.
    Yuan Y; Zuo M; Zhang S; Chen S; Feng W; Wang Z; Chen M; Liu Y
    Front Cell Neurosci; 2023; 17():1155982. PubMed ID: 37252189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
    Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
    Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
    Zhou S; Lu Y; Chen Y; Gan W
    Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model based on immunogenic cell death-related genes predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma.
    Dong P; Zhao L; Zhao L; Zhang J; Lu G; Zhang H; Ma M
    Transl Cancer Res; 2024 Jan; 13(1):249-267. PubMed ID: 38410237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.
    Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of a Novel Immunogenic Cell Death-Relevant Gene Signature Associated with Immune Landscape in Gastric Cancer.
    Meng Y; Jin Z; Wang M; Chen D; Zhu M; Huang Y; Xia S; Xiong Z
    Biochem Genet; 2023 Oct; 61(5):2092-2115. PubMed ID: 36943521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
    Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
    Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic signature based on immunogenic cell death score predicts outcomes and response to transcatheter arterial chemoembolization and immunotherapy in hepatocellular carcinoma.
    Zhang Y; Yang J; Xie S; Chen H; Zhong J; Lin X; Yu Z; Xia J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11411-11429. PubMed ID: 37382674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
    Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
    Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma.
    Jiang S; Dong Y; Wang J; Zhang X; Liu W; Wei Y; Zhou H; Shen L; Yang J; Zhu Q
    Front Immunol; 2023; 14():1207061. PubMed ID: 37662929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
    Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y
    Front Immunol; 2023; 14():1021678. PubMed ID: 36860853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a copper metabolism-related gene signature for predicting prognosis and immune response in glioma.
    Li L; Leng W; Chen J; Li S; Lei B; Zhang H; Zhao H
    Cancer Med; 2023 Apr; 12(8):10123-10137. PubMed ID: 36856182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of immunogenic cell death-related subtypes used for predicting survival and immunotherapy of endometrial carcinoma through a bioinformatics analysis.
    Liu Z; Luo Y; Su L; Hu X
    Medicine (Baltimore); 2023 Aug; 102(31):e34571. PubMed ID: 37543760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic cell death (ICD) genes predict immunotherapy response and therapeutic targets in acute myeloid leukemia (AML).
    Wen S; Lv X; Ma X; Deng S; Xie J; Yuan E
    Front Genet; 2024; 15():1419819. PubMed ID: 39205940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.